Yes, a potassium blood test can be wrong, and a falsely elevated result is one of the most frequent artefacts encountered in clinical chemistry laboratories. At Longevity Benchmark, we read the primary literature behind each biomarker we publish on, and separate what it supports from what gets repeated.
The commonest reason is pseudohyperkalemia, where potassium leaks out of blood cells after the draw rather than circulating at high levels inside the body. In a prospective emergency department study published in the Western Journal of Emergency Medicine, 66 low-risk patients with elevated, haemolysed potassium had a median initial reading of 5.8 mmol/L, but their median non-haemolysed repeat was 3.9 mmol/L, yielding a true positive rate of 0% (95% CI 0 to 6%).
The Verdict
Frequency of Spurious Potassium Results
Spurious potassium elevations represent one of the most common pre-analytical errors in laboratory medicine. Background haemolysis rates vary widely depending on clinical setting and collection method. In the Western Journal of Emergency Medicine report, the authors noted their institutional background haemolysis rate was 0.28% of chemistry samples, whereas an emergency department study cited in that paper found 32% of all samples had some degree of haemolysis.
Undetected cell damage can shift test results in both directions. In a study of 472 emergency department point-of-care blood gas samples published in Medicina, almost 12% were haemolysed. Those haemolysed specimens averaged 4.60 ± 0.11 mEq/L compared to 3.99 ± 0.03 mEq/L for intact specimens, representing a 0.61 mEq/L or 15.29% upward shift. Undetected haemolysis pushed 5.08% of normal samples into apparent hyperkalaemia and masked 15.2% of genuinely low potassium samples.
Severe spurious elevations at critical thresholds remain uncommon in general outpatient cohorts. In research by Seimiya and colleagues, unexplained serum potassium of 6.5 mmol/L or higher appeared in 8 of 73,846 outpatients (0.0081%) at a Japanese university hospital before a phlebotomy protocol change, dropping to 1 of 171,053 outpatients (0.00058%) afterward.
A genuine elevation in potassium remains a medical emergency that can provoke dangerous cardiac conduction blocks. Establishing whether a high result represents an in vitro artefact or true systemic hyperkalaemia requires an immediate, carefully collected repeat draw evaluated by a clinician.
Intracellular Potassium and the Red Cell Gradient
A steep concentration gradient separates potassium levels inside human blood cells from the surrounding fluid. Intracellular fluid contains approximately 140 mEq/L of potassium, whereas extracellular plasma contains only 4 to 5 mEq/L, according to StatPearls. This biological gradient means that red blood cells hold nearly thirty times more potassium than the liquid phase of blood.
The testing equipment influences how much released cellular potassium alters the reported value. Research in the Medical Journal Armed Forces India observed that indirect ion-selective electrode methods used in standard automated serum analysers read higher when intracellular contents mix into the specimen. In contrast, whole-blood direct ion-selective electrode analysers remain comparatively stable.
Draw Technique and Mechanical Interference at the Needle
Physical mechanics during venipuncture directly influence how much potassium enters the collection tube. As Saleh-Anaraki and colleagues in the American Journal of Medicine explained, muscular exercise releases potassium from forearm tissue while an inflated tourniquet prevents venous washout. MedlinePlus warns that repeated fist clenching and pumping before or during blood collection can temporarily inflate measured potassium.
Seimiya and colleagues found that among 86 healthy volunteers, a decrease of 0.2 mmol/L or greater between the first and third consecutive tubes occurred in 25.6% of participants who clenched their fists, compared to 6.7% without clenching. In 7 volunteers tested at 10-second intervals following 20 clench-and-release cycles, serum potassium dropped between 8.4% and 25.9% once clenching ceased.
Tourniquet duration creates measurable changes in circulating ions. Wiederkehr and Moe examined 8 healthy volunteers, observing an average plasma potassium rise of 0.2 mEq/L (ranging from 0.05 to 0.5 mEq/L) during tourniquet use. In the same study, three index patients investigated because their laboratory findings did not match their condition showed average increases of 1.6, 1.3, and 1.7 mEq/L between free-flowing and tourniquet-occluded collections.
Collection hardware also plays a substantial role. In an analysis of 4,513 emergency department specimens by Wollowitz and colleagues, the overall haemolysis rate was 12.5%. Blood drawn through intravenous catheters had a 14.6% haemolysis rate compared to 2.7% for butterfly needles, making collection device the strongest independent predictor (odds ratio 7.7). In catheter collections, small-gauge catheters, tubes filled to half or less, draws outside the antecubital fossa, difficult venipuncture, and tourniquet times of one minute or longer increased haemolysis. None of those factors increased haemolysis when drawing with a butterfly needle.
Needle diameter requires balance. Evaluating 20 fasting volunteers, Lippi and colleagues showed that 23 G needles did not introduce statistically or clinically significant error compared to 21 G needles. For 25 G needles, the authors observed increased potassium variability and concluded they cannot be universally recommended.
| Collection Factor | Observed Effect | Clinical Evidence |
|---|---|---|
| Fist clenching and pumping | 8.4% to 25.9% drop after stopping | Seimiya et al. showed 25.6% of clenching volunteers had drops >= 0.2 mmol/L between draws versus 6.7% without clenching. |
| Tourniquet stasis | 0.05 to 0.5 mEq/L rise in healthy volunteers | Wiederkehr and Moe found an average 0.2 mEq/L rise in 8 healthy adults, and up to 1.7 mEq/L in 3 evaluated index patients. |
| Catheter vs butterfly needle | 14.6% vs 2.7% haemolysis rate | Wollowitz et al. identified collection device as the strongest independent predictor of haemolysis (odds ratio 7.7). |
| 25 G butterfly needle | Increased potassium variability | Lippi and colleagues observed increased potassium variability with 25 G against 23 G; they do not state a mechanism. |
| Underfilled collection tubes | Elevated haemolysis rate | Tubes filled to half or less were among the factors associated with haemolysis in IV-catheter draws. |
Sample Transit, Delay, and Storage Temperature
Refrigeration, not warmth, is the dangerous delay. A 2026 study in Diagnostics found that storing whole blood at 5 °C raised measured potassium by 5.0% (95% CI 3.2 to 6.8%) at 4 hours and by 19.8% (95% CI 16.6 to 23.1%) at 8 hours, while room-temperature storage moved it by only 3.2% and 3.1% over the same intervals. In that study index case, an initial chilled reading of 6.4 mmol/L corrected to 5.1 mmol/L on a properly handled repeat draw.
Where a sample waits before it is spun can put a seasonal pattern into one patient's results. A report in CEN Case Reports described a patient who presented with hyperkalaemia only when blood was drawn between October and May, with normal levels observed between June and September. The clinic stored blood tubes near an unheated window for 4 to 8 hours before centrifugation. At 4 °C, potassium climbed to 7 mEq/L after 8 hours, whereas storing blood at 37 °C prevented any elevation.
Genetic variations can amplify cold-induced potassium leaks. In Frontiers in Medicine, researchers detailed familial pseudohyperkalemia caused by an autosomal dominant ABCB6 gene variant that increases red cell membrane permeability at lower temperatures. When chilled at 4 °C, the patient sample potassium surged from 3.75 mmol/L to 20.35 mmol/L, despite showing minor fluctuations at 20 °C and 37 °C. An immediate blood gas analysis confirmed true whole-blood potassium at 4.3 mmol/L, and the patient was discharged without medication.
Tube sequence also influences results. An investigation in Biochemia Medica evaluating 92 paired draws found that 18% of samples collected immediately after a tube containing K-EDTA showed potassium elevations of at least 0.3 mmol/L (the Clinical Laboratory Improvement Amendments 2019 total allowable error limit). However, none had detectable EDTA concentrations, demonstrating that order-of-draw potassium shifts in closed collection systems occur without EDTA carryover. Historically, K-EDTA contamination rates had been described as ranging from 3% to 25%.
Differences Between Clotted Serum and Unclotted Plasma
Serum potassium measurements routinely exceed plasma potassium measurements because clotting releases potassium from platelets. Authors in Cureus note that platelets release intracellular potassium during fibrin clot formation in serum tubes. Historically, pseudohyperkalemia is defined as a serum potassium increase of more than 0.4 mmol/L over plasma in the absence of symptoms or electrocardiogram changes, as highlighted in Endocrinology, Diabetes & Metabolism Case Reports.
Because 41 of 60 surveyed laboratories apply one reference interval to both serum and plasma, the same blood can read normal in one tube type and high in the other; we set out the bands themselves in our potassium blood test guide. Hortin and colleagues in the Journal of Applied Laboratory Medicine documented that plasma reference intervals can span from 3.47 to 4.38 mmol/L, while standard serum intervals commonly run 3.5 to 5.0 mmol/L or 3.6 to 5.2 mmol/L.
The UK Kidney Association recommends that urea and electrolytes are measured using paired lithium heparin and clotted serum samples from a large vein using gentle traction with prompt laboratory analysis if pseudohyperkalaemia is suspected. They add that a lithium heparin anti-coagulated specimen is the sample type of choice when rapid turnaround is required.
| Specimen Type | Collection Tube | Handling and Analytical Characteristics |
|---|---|---|
| Serum | Serum gel or red-top tube | Requires complete clotting before centrifugation, which releases platelet potassium into the liquid phase. |
| Plasma | Lithium heparin tube | Anticoagulant prevents clotting, so platelets do not release potassium into the sample. Plasma has its own failure mode: in reverse pseudohyperkalaemia it reads high while serum is normal. |
| Whole blood | Heparinised syringe or blood gas tube | Measured directly on point-of-care analysers, bypassing centrifuge delays and cellular release. |
Platelet and White Cell Interferences
Markedly elevated blood counts create substantial discrepancies between measured serum potassium and true circulating levels. Around 600 × 10⁹/L is the count usually quoted, and it discriminates poorly. Delgado and colleagues in EJIFCC derived a threshold of 598 × 10³/µL (95% CI 533 to 662) in 54 patients with essential thrombocytosis, but at a sensitivity of 0.67 and a specificity of 0.58, so the count alone neither confirms nor excludes the artefact, and the serum-to-plasma gap is what the laboratory actually reads.
The authors estimated that in 2019, 0.14% of potassium results in patients with thrombocytosis may have been interpreted incorrectly. Among their 94 results, 6.5% represented pseudohyperkalaemia episodes and 1.9% represented pseudonormokalaemia episodes where platelet release masked real potassium depletion.
Published cases show the gap scaling with the count rather than following a fixed rule. In essential thrombocytosis, counts between 533 and 694 × 10⁹/L produced a 0.9 mmol/L serum-to-plasma difference. A post-splenectomy patient at 914 × 10⁹/L produced a 2.0 mmol/L difference. A diabetic ketoacidosis case in Clinical Case Reports with platelets at 2,071 × 10⁹/L resulted in apparent treatment-resistant hyperkalaemia.
Whole-blood testing can resolve these discrepancies. In Cureus, a case series showed whole-blood heparinised analysis normalised potassium every time: platelets at 1,838,000/mm³ with serum potassium of 5.5 mEq/L yielded a whole-blood reading of 4.2; platelets at 1,118,000/mm³ with serum 5.5 gave 4.3; and platelets at 814,000/mm³ with serum 6.4 gave 4.7 mEq/L. Evaluating mean platelet volume alongside cell counts provides further haematologic context.
Elevated white blood cells introduce similar errors. In chronic lymphocytic leukaemia, Bnaya and colleagues found pseudohyperkalemia prevalence reaches up to 40%, particularly when leukocyte counts exceed 50 × 10⁹/L. Clinicians review total white blood cell count and evaluate for high white blood cell count to identify vulnerable specimens.
Reverse pseudohyperkalaemia presents the opposite challenge, where heparinised plasma reads falsely high while clotted serum remains normal. A 6-year retrospective series of 45 cases in 41 patients published in the Clinical Kidney Journal reported a median plasma potassium of 6.1 mEq/L against a median serum potassium of 4.4 mEq/L (a median difference of 1.4 mEq/L). In that cohort, 38% of cases received potassium-lowering treatments before clinicians recognised the artefact. Only 44% of samples had leukocytosis (WBC > 11 × 10³/mL), with a median WBC of 9.35 × 10³/mL, proving the phenomenon does not require extreme cell counts.
Clinical Evaluation and Confirmation Protocols
Clinicians evaluate abnormal potassium findings by reviewing patient symptoms, cardiac tracings, and sample integrity before changing medications. StatPearls states that because pseudohyperkalaemia is common, elevations in asymptomatic patients without characteristic ECG changes should be confirmed, and aggressive intervention withheld until the elevation is verified.
Laboratories typically call a sample haemolysed at 0.5 g/L (50 mg/dL) of free haemoglobin. What the laboratory then does with a flagged potassium is set by its own policy.
A structured clinical sequence confirms whether an abnormal reading requires intervention:
- Renal markers. Checking serum creatinine and calculating eGFR determines whether the kidneys are effectively clearing potassium.
- Metabolic panel review. Evaluating blood urea nitrogen, electrolytes, and acid-base status through our guide to the CMP blood test clarifies clinical context.
- Complete blood count. Screening for thrombocytosis above 600 × 10⁹/L or leukocytosis above 50 × 10⁹/L identifies haematologic causes of in vitro potassium release.
- Electrocardiogram. An immediate ECG checks for tall peaked T waves, PR prolongation, QRS widening, or conduction delays that indicate genuine cardiac toxicity.
- Paired repeat collection. Drawing simultaneous lithium heparin plasma and clotted serum tubes without fist pumping confirms true circulating concentrations.
Medical Risks of True Hyperkalemia
Recognising pre-analytical artefacts protects patients from inappropriate medical treatments, but identifying and managing genuine elevations still comes first. Where hyperkalaemia begins is not agreed: the UK Kidney Association sets it at 5.5 mmol/L, while American Family Physician treats 6.0 mEq/L as the clinically significant line. Our potassium blood test guide sets out the severity bands.
True hyperkalaemia can cause severe arrhythmias; StatPearls describes a sine-wave pattern and potential progression to asystole at 8 to 10 mEq/L. In clinical practice, distinguishing genuine potassium toxicity from collection error prevents tragic delays in resuscitation.
Wiederkehr and Moe emphasize that the explicit goal of identifying factitious hyperkalemia is to preclude unnecessary investigations and potentially hazardous interventions, while diagnosing and managing true hyperkalemia remains paramount. Spurious lab spikes mirror diagnostic pitfalls found in other routine markers, such as false A1c results, and highlight broader collection issues examined in at-home blood test accuracy.
Suspected lab errors should never lead patients to ignore an elevated report. An artefact is established only when a repeat test is drawn under controlled conditions and interpreted by a physician.
Frequently Asked Questions
Can a potassium blood test be wrong?
Yes, a potassium blood test can be falsely elevated due to sample collection and handling errors known as pseudohyperkalemia. Because potassium is thirty times more concentrated inside blood cells (approximately 140 mEq/L) than in fluid outside them (4 to 5 mEq/L), minor cell leakage during or after venipuncture elevates the reading. In a prospective emergency department study of haemolysed elevated samples in low-risk patients, 0% were confirmed as hyperkalemic on repeat testing. Clinicians verify unexpected elevations with a clean repeat draw before altering treatment.
How often are potassium blood tests wrong?
How often a potassium result is wrong depends heavily on clinical setting, draw technique, and sample handling. At one Japanese university hospital, unexplained potassium of 6.5 mmol/L or above was recorded in 8 of 73,846 outpatients (0.0081%) before a phlebotomy protocol change and in 1 of 171,053 (0.00058%) after it. No published figure covers outpatients generally; every rate on record is specific to one setting and one definition. In emergency department studies, haemolysis occurs in roughly 12% to 14% of catheter draws, whereas butterfly needle collections average around 2.7%.
What does a hemolyzed potassium sample mean?
A haemolysed potassium sample means that red blood cells ruptured during collection, transport, or processing, spilling their internal potassium into the surrounding liquid. Because intracellular potassium sits at roughly 140 mEq/L compared to 4 to 5 mEq/L in normal serum, even minor cell breakage inflates the test result. Laboratories typically call a sample haemolysed at 0.5 g/L (50 mg/dL) of free haemoglobin. What the laboratory then does with a flagged potassium is set by its own policy. Clinicians typically order a repeat draw to obtain an accurate baseline.
Can clenching your fist raise your potassium result?
Clenching or pumping your fist during blood collection can significantly raise measured potassium. Exercising forearm muscles releases intracellular potassium into regional veins, and tourniquet pressure prevents normal blood flow from clearing it. Research by Seimiya and colleagues revealed that repeated clenching produced a potassium drop of 8.4% to 25.9% within seconds after clenching stopped. The protocol change that cut pseudohyperkalaemia 14-fold at one hospital was procedural: draw from the basilic or cephalic vein without making a fist, or with minimal grip, and take the electrolyte tube after the others.
Does a tourniquet affect a potassium blood test?
A tourniquet can alter potassium levels by causing venous stasis that traps locally released potassium ions. In 8 healthy adults evaluated by Wiederkehr and Moe, standard tourniquet application produced an average potassium increase of 0.2 mEq/L, with documented shifts ranging from 0.05 to 0.5 mEq/L, while index patients showed spikes up to 1.7 mEq/L. In one 4,513-specimen study, a tourniquet time of a minute or more was associated with more haemolysis in draws taken through an intravenous catheter, but not in draws taken with a butterfly needle.
Why do they repeat a high potassium test?
Clinicians repeat unexpected high potassium tests because pseudohyperkalemia is common and treating an artefact exposes a patient to intervention they do not need. StatPearls states that because pseudohyperkalaemia is common, elevations in asymptomatic patients without characteristic ECG changes should be confirmed, and aggressive intervention withheld until the elevation is verified. Repeating the test using strict phlebotomy technique separates true medical emergencies from laboratory artefacts. Wiederkehr and Moe give preventing unnecessary investigation and potentially hazardous intervention as the reason to recognise it.
What is pseudohyperkalemia?
Pseudohyperkalemia refers to a laboratory finding where measured potassium appears elevated despite normal circulating potassium levels inside the body. It occurs when potassium leaks from red cells, platelets, or white cells after the blood leaves the vein. The condition is classically defined as a serum potassium reading more than 0.4 mmol/L higher than a simultaneous plasma reading without symptoms or electrocardiographic changes. Pseudohyperkalaemia describes a result that has already been shown to be spurious by a repeat draw. Until that repeat is done and read by a clinician, a high potassium is treated as real, because a genuine elevation can be an emergency.
Is serum or plasma potassium more accurate?
Plasma potassium provides a closer reflection of true circulating potassium because blood is collected with an anticoagulant that prevents clotting. When blood clots in a serum tube, platelets release their intracellular potassium stores, causing serum measurements to run roughly 0.2 to 0.4 mmol/L higher than plasma. Published cases show the gap scaling with the count rather than following a fixed rule: 0.9 mmol/L at platelets of 533 to 694 × 10⁹/L, and 2 mmol/L in a post-splenectomy patient at 914 × 10⁹/L. Anticoagulated plasma avoids platelet release, though clinicians consider reverse pseudohyperkalemia in complex cases.